Yennu, Sriram |
University Of Tx Md Anderson Can Ctr
United States |
A Combination Therapy to Treat Cancer-Related Fatigue |
5R01CA231521-05 |
Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis |
5R01CA222900-06 |
Counter, Christopher M |
Duke University
United States |
Adapting K-MDS to detect KRAS-mutant ctDNA |
5R21CA257816-02 |
Zhu, Yazhen |
University Of California Los Angeles
United States |
Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles |
1R01CA277530-01A1 |
Hinds, Pamela S |
Children'S Research Institute
United States |
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment |
5R01CA212190-05 |
Carter, Bob S |
Massachusetts General Hospital
United States |
Liquid Biopsy for treatment stratification of IDH1.R132H and EGFRvIII mutant gliomas |
5U01CA230697-05 |
Cole, Peter D |
Rutgers Biomedical And Health Sciences
United States |
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL |
7R01CA220568-05 |
Frazier, Anne Lindsay |
Dana-Farber Cancer Inst
United States |
Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors |
5UH3CA240688-05 |
Li, Feng |
University Of California Los Angeles
United States |
Novel ultra-short cell free DNA biomarkers for early detection of non-small cell lung cancer. |
1R21CA283665-01 |
Hoshida, Yujin |
Ut Southwestern Medical Center
United States |
Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis |
1U01CA288375-01 |